GRDN · Guardian Pharmacy Services, Inc.
$37.97
-0.31 (-0.81%)
At close · Aug 19
Market Cap
$2.41B
Shares
63.34M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$37.97
Open$38.44
Day$37.71–39.57
52W close$23.41–43.83
Avg vol 30d336K
Short int2.9M · 4.5% float · 9.6d
Short vol51%
Last earningsAug 6, 2026
DataSep 2024–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 6, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+8%
above
Price vs 50-day avg
−7%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
71%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−5%
trailing
6-month return
+15%
trailing
YTD return
+26%
this year
Relative strength
+3%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $41 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
+8% holders QoQ · +34 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.50% of float · ▲ +2.2% MoM · 9.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
185 holders — near 2-yr high, broad support
Squeeze score
54
elevated · 0–100
Fundamentals
Revenue growth
+18%
Y/Y
Gross margin
20%
expanding
Balance sheet
$46.6M
net cash
Quant / Vol
risk profile
Volatility
42%
annualized · 1-yr
Max drawdown
−23%
past year
ATR
5.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Revenue
· FY 2026
Initiated
$1.43B – $1.45B
prior FY $1.45B
midpoint −0.6% Y/Y
Prior guidance
period ended
· from the 8-K filed Jan 13, 2026
Adjusted EBITDA
· 2025 Guidance
$104M – $106M
Adjusted EBITDA Margin
· 2025 Guidance
7.4%
Guided vs delivered
· last 1 settled
Revenue
FY 2025
guided $1.43B – $1.45B
$1.45B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+8%
Bullish
Price vs 50-day avg
−7%
Bearish
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
71%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $41 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
+8% holders QoQ · +34 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.50% of float · ▲ +2.2% MoM · 9.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
185 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $23
Now $38 · 71%
Range high $44
vs 200-day avg +8%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 29.7M | Q2 2026 | — |
|
|
|||
| Adjusted EPS non-GAAP | $0.29 | Q2 2026 | — |
|
|
|||
| Full-service pharmacies | 54 | as of June 30, 2026 | — |
| Residents served | 210,000 | Q2 2026 | — |
|
|
|||
| Total pharmacies | 61 | Full Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GRDN
this stock
Guardian Pharmacy Services, Inc.
|
$2.41B | +26.2% | +17.9% | — | 4.5% |
|
HCA
HCA Healthcare, Inc.
|
$90.30B | -12.8% | +7.1% | 14.0 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.84B | -4.5% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.76B | +35.1% | +0.9% | 10.4 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.69B | +0.1% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GRDN | -1.6% | -4.5% | +14.8% | -4.0% | +26.2% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -1.1% | -7.4% | +3.3% | -6.9% | +13.4% |
Key facts
CIK
1802255
CUSIP
40145W101
13F (30d)
173 filings
173 filers
Visit website
Investor relations